Back to Journals » International Journal of Nanomedicine » Volume 6

SERS-based nanobiosensing for ultrasensitive detection of the p53 tumor suppressor

Authors Domenici F, Bizzarri AR, Cannistraro S

Published 19 September 2011 Volume 2011:6 Pages 2033—2042


Review by Single anonymous peer review

Peer reviewer comments 3

Fabio Domenici, Anna Rita Bizzarri, Salvatore Cannistraro
Biophysics and Nanoscience Centre, Faculty of Science, Università della Tuscia, Viterbo, Italy

Background: One of the main challenges in biomedicine is improvement of detection sensitivity to achieve tumor marker recognition at a very low concentration when the disease is not significantly advanced. A pivotal role in cancer defense is played by the p53 tumor suppressor, therefore its detection with high sensitivity may contribute considerably to early diagnosis of cancer. In this work, we present a new analytical method based on surface-enhanced Raman spectroscopy which could significantly increase the sensitivity of traditional bioaffinity techniques. p53 molecules were anchored to gold nanoparticles by means of the bifunctional linker 4-aminothiophenol (4-ATP). The characteristic vibrational bands of the p53-4-ATP nanoparticle system were then used to identify the p53 molecules when they were captured by a recognition substrate comprising a monolayer of azurin in molecules possessing significant affinity for this tumor suppressor. The Raman signal enhancement achieved by 4-ATP-mediated crosslinking of p53 to 50 nm gold nanoparticles enabled detect of this protein at a concentration down to 5 × 10-13 M.

Keywords: surface-enhanced Raman spectroscopy, p53, ultrasensitive detection, atomic force microscopy

Creative Commons License © 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.